Abstract
The treatment for bronchoconstriction should be aimed at the treatment of bronchoedema, bronchospasm, hypersecretion of mucous and ventilation-perfusion imbalance. Stimulation of β-adrenergic receptors and blockade of α-adrenergic receptors and cholinergic receptors can be considered as the therapeutic approach to bronchoconstriction, and the effectiveness of β-stimulants, α-blockers and anticholinergic compound on bronchospasm has been reported. It has been recognized that new β-stimulants have some different actions, and the effects of β-stimulants on bronchospasm are increased when α-blockers and β-stimulants are used together. Corticosteroids have been employed for the treatment of bronchoedema and hypersecretion of mucous. It has also been observed that β-stimulants and cromeglycate protect against exercise induced bronchospasm and allergen induced bronchoconstriction.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
